GW-296115

N/A

Report date: 2025/03/21 11:07:51
NME

Base Information

Drug NameGW-296115
Drug Alias NameGW-296115
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase BRSK2 inhibitorsSerine/threonine-protein kinase BRSK1 inhibitors
TargetsSerine/threonine-protein kinase BRSK2Serine/threonine-protein kinase BRSK1
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Plc
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A